Table of Contents
Trainline shares rose as fewer strike days and more customers switching to digital tickets boosted business.
The FTSE 250 company rose 9.2 percent, or 27.6 pence, to 327.8 pence after saying its ticket sales, revenue and profit should be stronger than expected for the year to the end of February 2025.
The online ticketing app’s revenue rose 17 per cent to £229m in the six months to the end of August.
Ticket sales rose 14 per cent to £3 billion, including a 15 per cent rise to £2 billion in the UK. There was also a strong performance in its international rail business, led by Spain and Italy.
All aboard: Trainline rose 8.1%, or 24.4p, to 324.6p after saying its ticket sales, revenue and profits should be better than expected for the year to the end of February 2025.
Katie Cousins, analyst at Shore Capital, said: “We believe Trainline has an unrivalled presence in the UK, with growth expected to be supported by increasing digitalisation.”
The FTSE 100 rose 0.6 per cent, or 47.03 points, to 8,240.97 and the FTSE 250 rose 0.8 per cent, or 158.52 points, to 20,695.77.
Markets in Europe rallied after the European Central Bank cut interest rates for the second time this year.
Germany’s main benchmark index gained 1 percent, while France’s CAC 40 added 0.5 percent.
In London, Diageo rallied after Bank of America analysts said the Ciroc owner is “overcoming the crisis” and that “the worst is over” as growth should improve this year for the international spirits market.
The broker raised its rating on the stock to buy from neutral and increased its target price by 200p to 2,800p. The shares rose 3 per cent, or 72p, to 2,506p.
Observatory of actions – NCC
Cybersecurity firm NCC has raised its forecasts after…
Business performed well during a typically quiet period.
Revenue of £100m and profit of £3.5m were expected for the four months to the end of September.
But strong trading results at its cybersecurity division have boosted forecasts: revenue is now expected to hit £104m along with a profit of £6m.
Shares rose 10.6 percent, or 16 pence, to 167.6 pence, taking annual gains to 30 percent.
GSK said a seasonal flu vaccine it is developing will move to the next stage of clinical trials after positive results were obtained in younger and older adults who participated.
The announcement came a day after the pharmaceutical giant said its herpes drug had failed to impress. It also settled a separate case involving whether its heartburn drug Zantac increased the risk of developing cancer.
Shares fell 1 percent, or 16 pence, to 1,638.5 pence.
Pest control company Rentokil remained under pressure a day after warning that a slowdown in North America will hit annual profits.
The shares, which fell 20 percent yesterday, were down another 2.1 percent, or 8.1 pence, at 372 pence.
Spire Healthcare is cashing in on working-age patients opting for private health insurance, but the shares fell 0.2 percent, or 0.5 pence, to 249.5 pence. Gulf Marine Services, which
The company, which provides support vessels to service oil and gas platforms and offshore wind farms, has raised its profit forecast after winning a five-year contract, lifting it 11 percent, or 1.7 pence, to 17.2 pence.
Investment fund Brooks Macdonald, down 2.1 per cent, or 40p, at 1,855p, is to sell its international business to wealth manager Canaccord in a deal worth up to 50.85 million pounds.
Profits fell 47.7 per cent to £11.6m in the year to the end of June due to a one-off charge, while customers withdrew more money than they deposited.
Marlowe, a business consultant backed by Lord Ashcroft, wants to spin off its occupational health division and list it on AIM this month.
Shares gained 5.8 percent, or 25p, to 455p. And Heiq slumped 44 percent, or 3.98p, to 5.07p after the textile technology company warned it needed to raise more money to stay afloat.
DIY INVESTMENT PLATFORMS
AJ Bell
AJ Bell
Easy investment and ready-to-use portfolios
Hargreaves Lansdown
Hargreaves Lansdown
Free investment ideas and fund trading
interactive investor
interactive investor
Flat rate investing from £4.99 per month
Saxo
Saxo
Get £200 back in trading commissions
Trade 212
Trade 212
Free treatment and no commissions per account
Affiliate links: If you purchase a product This is Money may earn a commission. These offers are chosen by our editorial team as we believe they are worth highlighting. This does not affect our editorial independence.